These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Microarray analyses in bladder cancer cells: inhibition of hTERT expression down-regulates EGFR. Kraemer K, Schmidt U, Fuessel S, Herr A, Wirth MP, Meye A. Int J Cancer; 2006 Sep 15; 119(6):1276-84. PubMed ID: 16615118 [Abstract] [Full Text] [Related]
23. Early upregulation of cyclooxygenase-2 in human papillomavirus type 16 and telomerase-induced immortalization of human esophageal epithelial cells. Zhuang ZH, Tsao SW, Deng W, Wang JD, Xia HH, He H, Feng HC, Wang LD, Gu Q, Lam SK, Lin MC, Kung HF, Wong BC. J Gastroenterol Hepatol; 2008 Oct 15; 23(10):1613-20. PubMed ID: 18717758 [Abstract] [Full Text] [Related]
24. Efficient inhibition of human telomerase activity by antisense oligonucleotides sensitizes cancer cells to radiotherapy. Ji XM, Xie CH, Fang MH, Zhou FX, Zhang WJ, Zhang MS, Zhou YF. Acta Pharmacol Sin; 2006 Sep 15; 27(9):1185-91. PubMed ID: 16923339 [Abstract] [Full Text] [Related]
26. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line. Shoukrun R, Veenman L, Shandalov Y, Leschiner S, Spanier I, Karry R, Katz Y, Weisinger G, Weizman A, Gavish M. Pharmacogenet Genomics; 2008 Nov 15; 18(11):977-88. PubMed ID: 18806692 [Abstract] [Full Text] [Related]
27. Human telomerase reverse transcriptase antisense treatment downregulates the viability of prostate cancer cells in vitro. Schindler A, Fiedler U, Meye A, Schmidt U, Füssel S, Pilarsky C, Herrmann J, Wirth MP. Int J Oncol; 2001 Jul 15; 19(1):25-30. PubMed ID: 11408918 [Abstract] [Full Text] [Related]
28. Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA. Fuessel S, Herrmann J, Ning S, Kotzsch M, Kraemer K, Schmidt U, Hakenberg OW, Wirth MP, Meye A. Cancer Lett; 2006 Feb 08; 232(2):243-54. PubMed ID: 16458121 [Abstract] [Full Text] [Related]
29. Synthetic nucleic acids as potential therapeutic tools for treatment of bladder carcinoma. Fuessel S, Meye A, Kraemer K, Kunze D, Hakenberg OW, Wirth MP. Eur Urol; 2007 Feb 08; 51(2):315-26; discussion 326-7. PubMed ID: 16935415 [Abstract] [Full Text] [Related]
31. Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. Li S, Rosenberg JE, Donjacour AA, Botchkina IL, Hom YK, Cunha GR, Blackburn EH. Cancer Res; 2004 Jul 15; 64(14):4833-40. PubMed ID: 15256453 [Abstract] [Full Text] [Related]
32. [Inhibition of A549 cells by polybutylcyanoacrylate nanoparticles loaded with antisense oligodeoxynucleotide of hTERT mRNA]. Zhang YY, Fu CJ, Zhang ZZ. Yao Xue Xue Bao; 2006 May 15; 41(5):446-51. PubMed ID: 16848322 [Abstract] [Full Text] [Related]
35. Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cells. Kunze D, Wuttig D, Fuessel S, Kraemer K, Kotzsch M, Meye A, Grimm MO, Hakenberg OW, Wirth MP. Anticancer Res; 2008 May 15; 28(4B):2259-63. PubMed ID: 18751404 [Abstract] [Full Text] [Related]
36. [Inhibition of telomerase with hTERT antisense enhances TNF-alpha-induced apoptosis in prostate cancer cells PC3]. Gao XD, Chen YR. Zhonghua Nan Ke Xue; 2007 Aug 15; 13(8):723-6. PubMed ID: 17918713 [Abstract] [Full Text] [Related]
40. Visualizing the down-regulation of hTERT mRNA expression using gold-nanoflare probes and verifying the correlation with cancer cell apoptosis. Sun H, Hong M, Yang Q, Li C, Zhang G, Yue Q, Ma Y, Li X, Li CZ. Analyst; 2019 May 07; 144(9):2994-3004. PubMed ID: 30892312 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]